Seed · 2026-10-27 · Healthcare

Atlas Bio raises $12.5M

AI Score

Amount

$12.5M

Round

Seed

Lead

Creandum

Basel, CH

Why it matters: Atlas Bio's $12.5M round shows how in silico trial startups pitch simulation as a cheaper filter before Phase II, while the piece flags that regulatory acceptance remains the open question.

Atlas Bio, a Basel-based startup founded in 2024 by former autonomous-driving engineers.

Participants:: First Momentum Ventures, LEA Partners
Source:: Tech Funding News ↗ · Midu summary

Deal Dossier PRO

Pro feature

Deal Dossier for Atlas Bio

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro

Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

More deals with Creandum

Recent Healthcare rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

Midu WeeklyMondays · funding trends and top roundsSee a sample issue →SF WeeklyFridays · San Francisco startups, rounds and eventsSee a sample issue →

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing